Circulating Hybrid Cells As A Novel Liquid Biomarker Of Treatment Response In Gastrointestinal Cancers

Brett S Walker,Thomas L Sutton,Luai Zarour,John G Hunter,Stephanie G Wood,V Liana Tsikitis,Daniel O Herzig,Charles D Lopez,Emerson Y Chen,Skye C Mayo,Melissa H Wong

ANNALS OF SURGICAL ONCOLOGY（2021）

引用 5|浏览25

暂无评分

摘要

Circulating hybrid cells are a novel blood-based biomarker with potential for monitoring treatment response and disease progression to help guide decisions for further systemic therapy, definitive resection, and post-therapy surveillance. Additional validation studies of CHCs are warranted.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要